A

American Oncology Network | Hope Cancer Care of Nevada

Research site

(Unclaimed)

Location

6827 West Tropicana Ave, Las Vegas, Nevada, United States of America

Site insights

Top conditions

Top treatments

Paclitaxel

Nivolumab

Carboplatin

Cisplatin

Capecitabine

Ipilimumab

Docetaxel

Gemcitabine Hydrochloride

Pembrolizumab

Etoposide

Parent organization

This site is a part of American Oncology Network

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 114 total trials

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenan...

Active, not recruiting

Multiple Myeloma

Drug: Lenalidomide

Drug: Daratumumab/rHuPH20

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

This phase III trial compares the effect of usual treatment with trastuzumab emtansine (T-DM1) alone vs. T-DM1 in combination with tucatinib. T-DM1 i...

Active, not recruiting

Invasive Breast Carcinoma

Synchronous Bilateral Breast Carcinoma

Biological: Trastuzumab Emtansine

Other: Quality-of-Life Assessment

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with me...

Enrolling

Recurrent Meningioma

NF2 Gene Mutation

Drug: Vismodegib

Drug: Abemaciclib